{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:45:59Z","timestamp":1790790359397,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1053\/j.jvca.2017.10.032","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T15:18:02Z","timestamp":1509117482000},"page":"1013-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"title":["Vasoplegia After Cardiovascular Procedures\u2014Pathophysiology and Targeted Therapy"],"prefix":"10.1053","volume":"32","author":[{"given":"Shahzad","family":"Shaefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Mittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Klick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia S.","family":"Ivascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Gutsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.T.","family":"Augoustides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2017.10.032_bib1","first-page":"619","article-title":"Vasoplegic syndrome after open heart surgery","volume":"39","author":"Gomes","year":"1998","journal-title":"J Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib2","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.10.032_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1053-0770(98)90017-9","article-title":"Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: A role for vasopressin administration","volume":"12","author":"Mets","year":"1998","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2017.10.032_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: Pathophysiology, risk factors and treatment","volume":"349","author":"Omar","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.jvca.2017.10.032_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semtcvs.2010.09.007","article-title":"Vasoplegia during cardiac surgery: Current concepts and management","volume":"22","author":"Fischer","year":"2010","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2044.2006.04779.x","article-title":"Association between vasopressor dependence and early outcome in patients after cardiac surgery","volume":"61","author":"Weis","year":"2006","journal-title":"Anaesthesia"},{"key":"10.1053\/j.jvca.2017.10.032_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1042\/bst0250919","article-title":"Role of poly(ADP-ribose) synthetase activation in the suppression of cellular energetics in response to nitric oxide and peroxynitrite","volume":"25","author":"Szabo","year":"1997","journal-title":"Biochem Soc Trans"},{"key":"10.1053\/j.jvca.2017.10.032_bib9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1213\/01.ANE.0000177117.80058.4D","article-title":"Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies","volume":"101","author":"Hauser","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.10.032_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock","volume":"32","author":"Lopez","year":"2004","journal-title":"Critical Care Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.10.032_bib12","first-page":"15","article-title":"Elevated plasma vasopressin concentrations during endotoxin and E. coli shock","volume":"6","author":"Wilson","year":"1981","journal-title":"Adv Shock Res"},{"key":"10.1053\/j.jvca.2017.10.032_bib13","first-page":"H491","article-title":"Vasopressin modulates K(+)-channel activities of cultured smooth muscle cells from porcine coronary artery","volume":"263","author":"Wakatsuki","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jvca.2017.10.032_bib14","first-page":"F433","article-title":"AVP inhibits LPS- and IL-1beta-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells","volume":"276","author":"Umino","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jvca.2017.10.032_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1213\/00000539-199710000-00011","article-title":"The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations","volume":"85","author":"Hall","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.10.032_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.112.3.676","article-title":"Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies","volume":"112","author":"Wan","year":"1997","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2017.10.032_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/jcan.2002.29672","article-title":"Hyperprocalcitonemia is related to noninfectious postoperative severe systemic inflammatory response syndrome associated with cardiovascular dysfunction after coronary artery bypass graft surgery","volume":"16","author":"Kerbaul","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2017.10.032_bib18","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/CIRCULATIONAHA.115.020894","article-title":"Gastrointestinal and liver issues in heart failure","volume":"133","author":"Sundaram","year":"2016","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.10.032_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent","volume":"116","author":"Argenziano","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib20","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1186\/cc10516","article-title":"Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration","volume":"15","author":"Colson","year":"2011","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2017.10.032_bib21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00134-015-3822-1","article-title":"A systematic review and meta-analysis of early goal-directed therapy for septic shock: The ARISE, ProCESS and ProMISe Investigators","volume":"41","author":"Angus","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis Campaign: International Guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2015","journal-title":"Critical Care Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1213\/ANE.0000000000001096","article-title":"Risk factors involved in central-to-radial arterial pressure gradient during cardiac surgery","volume":"122","author":"Fuda","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.10.032_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8090-5-17","article-title":"Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting: A double-blind randomized study","volume":"5","author":"Papadopoulos","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bpa.2008.02.010","article-title":"Role of vasopressinergic V1 receptor agonists in the treatment of perioperative catecholamine-refractory arterial hypotension","volume":"22","author":"Lange","year":"2008","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1053\/j.jvca.2017.10.032_bib26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1403612","article-title":"Liberal or restrictive transfusion after cardiac surgery","volume":"372","author":"Murphy","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.13-2104","article-title":"Early management of severe sepsis: Concepts and controversies","volume":"145","author":"Marik","year":"2014","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2017.10.032_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","article-title":"Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality","volume":"39","author":"Boyd","year":"2011","journal-title":"Critical Care Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib29","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/CCM.0b013e318174db05","article-title":"Actual incidence of global left ventricular hypokinesia in adult septic shock","volume":"36","author":"Vieillard-Baron","year":"2008","journal-title":"Critical Care Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib30","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2017.2841","article-title":"Association between US norepinephrine shortage and mortality among patients with septic shock","volume":"317","author":"Vail","year":"2017","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.10.032_bib32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2017.10.032_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0b013e31823778ee","article-title":"Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis","volume":"40","author":"De Backer","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.athoracsur.2006.08.041","article-title":"Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: A systematic literature review","volume":"83","author":"Egi","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized Clinical Trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.10.032_bib39","doi-asserted-by":"crossref","unstructured":"Morales DL, Garrido MJ, Madigan JD, et al. A double-blind randomized trial: Prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg;75:926\u201330.","DOI":"10.1016\/S0003-4975(02)04408-9"},{"key":"10.1053\/j.jvca.2017.10.032_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2017.10.032_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0014-5793(92)80910-9","article-title":"NO., CO and .OH. Endogenous soluble guanylyl cyclase-activating factors","volume":"307","author":"Schmidt","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1053\/j.jvca.2017.10.032_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejcts.2005.07.011","article-title":"Vasoplegic syndrome\u2014the role of methylene blue","volume":"28","author":"Shanmugam","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib43","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.jvca.2015.11.019","article-title":"Serotonin syndrome after methylene blue administration during cardiac surgery: A case report and review","volume":"30","author":"Wolvetang","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2017.10.032_bib44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1067\/mtc.2001.115153","article-title":"Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation","volume":"122","author":"Kofidis","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-5223(99)70161-3","article-title":"Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery","volume":"118","author":"Yiu","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib47","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?","volume":"125","author":"Leyh","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass","volume":"103","author":"Maslow","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.10.032_bib49","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"Ozal","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac operation: Early administration improves survival","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib51","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1053\/j.jvca.2013.02.026","article-title":"Methylene blue is associated with poor outcomes in vasoplegic shock","volume":"27","author":"Weiner","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2017.10.032_bib52","doi-asserted-by":"crossref","first-page":"e0142605","DOI":"10.1371\/journal.pone.0142605","article-title":"Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock: A systematic review and meta-analysis of randomized trials","volume":"10","author":"Belletti","year":"2015","journal-title":"PloS One"},{"key":"10.1053\/j.jvca.2017.10.032_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib54","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.10.032_bib55","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(15)00273-1","article-title":"Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): A randomised, double-blind, placebo-controlled trial","volume":"386","author":"Whitlock","year":"2015","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2017.10.032_bib56","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/jama.2012.14144","article-title":"Intraoperative high-dose dexamethasone for cardiac surgery: A randomized controlled trial","volume":"308","author":"Dieleman","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.10.032_bib57","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","article-title":"Hydrocortisone, vitamin C and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study","volume":"151","author":"Marik","year":"2017","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2017.10.032_bib58","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.jvca.2016.08.019","article-title":"Hydroxocobalamin as a rescue treatment for refractory vasoplegic syndrome after prolonged cardiopulmonary bypass","volume":"31","author":"Burnes","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2017.10.032_bib59","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.athoracsur.2013.08.050","article-title":"The use of high-dose hydroxocobalamin for vasoplegic syndrome","volume":"97","author":"Roderique","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2017.10.032_bib60","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.jemermed.2011.03.012","article-title":"Woman with red urine: Hydroxocobalamin-induced chromaturia","volume":"43","author":"Geraci","year":"2012","journal-title":"J Emerg Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.thromres.2013.07.002","article-title":"Use of antiplatelet agents in sepsis: A glimpse into the future","volume":"133","author":"Akinosoglou","year":"2014","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2017.10.032_bib62","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7990","article-title":"Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): A randomized, controlled pilot study","volume":"13","author":"Morelli","year":"2009","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2017.10.032_bib63","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bja\/aen017","article-title":"Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: The DOBUPRESS study","volume":"100","author":"Morelli","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2017.10.032_bib64","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/CCM.0000000000000420","article-title":"Selepressin in septic shock: Sharpening the VASST effects of vasopressin?","volume":"42","author":"Marks","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2017.10.032_bib65","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): A pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2017.10.032_bib66","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077017308169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077017308169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T04:04:25Z","timestamp":1570248265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077017308169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1053077017308169"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2017.10.032","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasoplegia After Cardiovascular Procedures\u2014Pathophysiology and Targeted Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2017.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}